LegoChem Biosciences, Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported negative sales was KRW 0.0004 million compared to KRW 0.00063 million a year ago. Net loss was KRW 45,091.79 million compared to KRW 23,391.23 million a year ago.

Basic loss per share from continuing operations was KRW 1,851 compared to KRW 970 a year ago. Diluted loss per share from continuing operations was KRW 1,851 compared to KRW 970 a year ago. Basic loss per share was KRW 1,851 compared to KRW 970 a year ago.